The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome

• Status: Completed
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates the efficacy and safety in improving ovarian function of polycystic ovarian syndrome in adults. Half of patients will receive Tung's acupuncture therapy, while the other half will receive Diane-35(CPA/EE) as the control group.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Hospital of Integrated Traditional Chinese and Western Medicine
• Treatments: Cyproterone; Cyproterone Acetate; Cyproterone acetate, ethinyl estradiol drug combination; Ethinyl Estradiol

Criteria

Inclusion Criteria:

1. Chinese;

2. 18-45 years old;

3. to meet the diagnostic criteria for polycystic ovary syndrome;

4. no need for pregnancy in the next six months;

5. volunteering to join this research and give informed consent prior to receiving treatment.

Exclusion Criteria:

1. hypertensive patients with blood pressure exceed 160/100 mmHg;

2. a history of thrombosis,cerebrolvascular diseases, cancer, liver disease or liver dysfuction, hyperlipidemia, mental disorder, and severe infection;

3. having taken any pharmacological treatments affecting reproductive endocrine system;

4. having received acupuncture in the previous three months;

5. smoking more than 15 cigarettes per day;

6. having pacemakers, metal allergies or severe fear of acupuncture.